v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Operating Activities:    
Net loss $ (24,629,291) $ (1,590,059)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Amortization of debt discount 360,551 11,231
Depreciation 303,312 0
Impairment of fixed assets and land 4,828,220 0
Change in fair value of cryptocurrency 34 4,599
Change in fair value of derivative liabilities (18,892,429) 1,795,664
Day one interest charge on derivative liabilities 5,665,276 0
Stock-based compensation 29,302,270 0
Loss on settlement of Notes Payable 148,053 (124,562,621)
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (17,423) 18,890
Accounts payable and accrued expenses 550,241 68,087
Accrued payroll 1,251,860 954,889
Deferred Revenue 303,613 0
Net cash provided by operating activities (825,713) 17,680
Investing Activities:    
Cash paid for business acquisition (183,000) 0
Advance of unsecured funds in connection with business acquisition (513,827) 0
Purchase of Property & Equipment (47,916) 0
Purchase of cryptocurrencies 0 (4,600)
Net cash provided by (used in) investing activities (744,743) (4,600)
Financing Activities:    
Proceeds from notes payable 1,327,000 0
Proceeds from issuance of common shares, net of offering costs 500,000 0
Proceeds from related party advances 0 16,725
Payments of related party advances (8,280) 0
Payments of convertible notes 0 (30,000)
Net cash used in financing activities 1,818,720 (13,275)
Net change in cash 248,264 (195)
Cash - beginning of period 103 298
Cash - end of period 248,367 103
Supplemental Disclosures:    
Interest paid 0 0
Income taxes paid 0 0
Supplemental Disclosures of Noncash Financing Information:    
Shares issued for business acquisition 3,150,616 0
Note issued for business acquisition 1,750,000 0
Shares issued for settlement of accrued salary 1,539,961 0
Series D preferred issued for settlement of accrued salary 772,000 0
Modification of stock options for settlement of accrued salary 100,000 0
Conversion of notes payable and derivative liabilities 1,418,466 0
Relief of warrant derivative liability upon settlement of notes 52,096 0
Relief of warrant derivative liability upon exercise of warrants 4,028,465
Establishment of new derivative liability on warrants 31,395,924 0
Shares issued for inducement into convertible notes 581,557 0
Derivative liability upon note issuance 210,857 0
Shares issued for deferred offering costs 495,000 0
Shares issued for cashless exercise of stock warrants 124,102 0
Shares issued for cashless exercise of stock options 404,005 0
Convertible note issued for accounts payable $ 20,000 $ 0